Michael Akers

Dr. Michael Akers


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2023 in Cancers
Verified
Journal Article
Open access
PDF file
MSMartin Iganz Schauer
Martin Iganz Schauer
EJErnst Michael JUNG
Ernst Michael JUNG
NSNatascha Platz Batista Da Silva
Natascha Platz Batista Da Silva
MAMichael Akers
Michael Akers
ELElena Loch
Elena Loch
MRMichael Ried
Michael Ried
Background: The intraoperative detection of solitary pulmonary nodules (SPNs) continues to be a major challenge, especially in minimally invasive video-assisted thoracic surgery (VATS). The location, size, and intraoperative frozen section result of SPNs are decisive regarding the extent of lung resection. This feasibility study investigates the technical applicability of intraoperative contrast-enhanced ultrasonography (Io-CEUS) in minimally invasive thoracic surgery. Methods: In this prospective, monocentric clinical feasibility study, n = 30 patients who underwent Io-CEUS during elective minimally invasive lung resection for SPNs between October 2021 and February 2023. The primary endpoint was the technical feasibility of Io-CEUS during VATS. Secondary endpoints were defined as the detection and characterization of SPNs. Results: In all patients (female, n = 13; mean age, 63 ± 8.6 years) Io-CEUS could be performed without problems during VATS. All SPNs were detected by Io-CEUS (100%). SPNs had a mean size of 2.2 cm (0.5–4.5 cm) and a mean distance to the lung surface of 2.0 cm (0–6.4 cm). B-mode, colour-coded Doppler sonography, and contrast-enhanced ultrasound were used to characterize all tumours intraoperatively. Significant differences were found, especially in vascularization as well as in contrast agent behaviour, depending on the tumour entity. After successful lung resection, a pathologic examination confirmed the presence of lung carcinomas (n = 17), lung metastases (n = 10), and benign lung tumours (n = 3). Conclusions: The technical feasibility of Io-CEUS was confirmed in VATS before resection regarding the detection of suspicious SPNs. In particular, the use of Doppler sonography and contrast agent kinetics revealed intraoperative specific aspects depending on the tumour entity. Further studies on Io-CEUS and the application of an endoscopic probe for VATS will follow.

24 July 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
MSMartin Iganz Schauer
Martin Iganz Schauer
EJErnst Michael JUNG
Ernst Michael JUNG
HHHans-Stefan Hofmann
Hans-Stefan Hofmann
NSNatascha Platz Batista da Silva
Natascha Platz Batista da Silva
MAMichael Akers
Michael Akers
MRMichael Ried
Michael Ried
Background: Suspicious tumors of the lung require specific staging, intraoperative detection, and histological confirmation. We performed an intrathoracic, intraoperative contrast-enhanced ultrasound (Io-CEUS) for characterization of lung cancer. Methods: Retrospective analysis of prospectively collected data on the application of Io-CEUS in thoracic surgery for patients with operable lung cancer. Analysis of the preoperative chest CT scan and FDG-PET/CT findings regarding criteria of malignancy. Immediately before lung resection, the intrathoracic Io-CEUS was performed with a contrast-enabled T-probe (6–9 MHz—L3-9i-D) on a high-performance ultrasound machine (Loqic E9, GE). In addition to intraoperative B-mode, color-coded Doppler sonography (CCDS), or power Doppler (macrovascularization) of the lung tumor, contrast enhancement (Io-CEUS) was used after venous application of 2.4–5 mL sulfur hexafluoride (SonoVue, Bracco, Italy) for dynamic recording of microvascularization. The primary endpoint was the characterization of operable lung cancer with Io-CEUS. Secondly, the results of Io-CEUS were compared with the preoperative staging. Results: The study included 18 patients with operable lung cancer, who received Io-CEUS during minimally invasive thoracic surgery immediately prior to lung resection. In the chest CT scan, the mean size of the lung tumors was 2.54 cm (extension of 0.7–4.5 cm). The mean SUV in the FDG-PET/CT was 7.6 (1.2–16.9). All lung cancers were detected using B-mode and power Doppler confirmed macrovascularization (100%) of the tumors. In addition, Io-CEUS showed an early wash-in with marginal and mostly simultaneous central contrast enhancement. Conclusions: The intrathoracic application of Io-CEUS demonstrated a peripheral and simultaneous central contrast enhancement in the early phase, which seems to be characteristic of lung cancer. In comparison to preoperative imaging, Io-CEUS was on par with the detection of malignancy and offers an additional tool for the intraoperative assessment of lung cancer before resection.

Verified
Journal Article
Open access
PDF file
NSNikolai Schmid
Nikolai Schmid
VGVadim Gorte
Vadim Gorte
MAMichael Akers
Michael Akers
Niklas VerlohNiklas Verloh
Niklas Verloh
MHMichael Haimerl
Michael Haimerl
POPatrick Ostheim
Patrick Ostheim
Computed tomography (CT) is a major source of low-dose ionizing radiation exposure in medical imaging. Risk assessment at this dose level is difficult and relies on the hypothetical linear no-threshold model. To address the response to such low doses in patients undergoing CT scans, we examined radiation-induced alterations at the transcriptomic and DNA damage levels in peripheral blood cells. Peripheral whole blood of 60 patients was collected before and after CT. Post-CT samples were obtained 4–6 h after scan (n = 28, in vivo incubation) or alternatively immediately after the CT scan, followed by ex vivo incubation (n = 32). The gene expression of known radiation-responsive genes (n = 9) was quantified using qRT-PCR. DNA double-strand breaks (DSB) were assessed in 12 patients through microscopic γ-H2AX + 53BP1 DSB focus staining. The mean dose–length product (DLP) across all scans was 561.9 ± 384.6 mGy·cm. Significant differences in the median differential gene expression (DGE) were detected between in vivo and ex vivo incubation conditions, implicating that ex vivo incubation masked the true effect in low-dose settings. The median DGE of in vivo-incubated samples showed a significant upregulation of EDA2R, MIR34AHG, PHLDA3, DDB2, FDXR, and AEN (p ranging from <0.001 to 0.041). In vivo, we observed a linear dose-dependent upregulation for several genes and an explained variance of 0.66 and 0.56 for AEN and FDXR, respectively. DSB focus analysis revealed a slight, non-significant increase in the average DSB damage post-exposure, at a mean DLP of 321.0 mGy·cm. Our findings demonstrate that transcriptional biomarkers are sensitive indicators of low-dose radiation exposure in medical imaging and could prove themselves as clinically applicable biodosimetry tools. Furthermore, the results underscore the need for dose optimization.

22 November 2024 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Open access
MKMaximilian Kerschbaum
Maximilian Kerschbaum
DPDaniel Pangerl
Daniel Pangerl
LHLeopold Henssler
Leopold Henssler
MAMichael Akers
Michael Akers
FZFlorian Zeman
Florian Zeman
LKLisa Klute
Lisa Klute
The increasing incidence of proximal humeral fractures (PHF) poses complex challenges in determining the optimal therapeutic strategies due to the diverse fracture patterns and individual patient characteristics. Traumatologists and orthopedic surgeons face significant decisions, as potential consequences such as pain, functional limitations, and complications may significantly affect patients' quality of life. Given the varying viewpoints on appropriate treatment modalities, a thorough examination of current care practices is crucial. An adaptive online survey was conducted to present realistic case scenarios, aimed at elucidating decision-making processes in the management of proximal humeral fractures. This survey encompassed relevant patient and fracture-related variables, employing a dynamic querying algorithm that featured up to 48 conceivable case scenarios. Analysis of 7012 case scenarios unveiled significant differences in treatment preferences across distinct patient age groups. Plate osteosynthesis emerged as the preferred modality for individuals under 50 years of age with complex fracture patterns. On the other hand, a balanced consideration between plate osteosynthesis and reverse shoulder arthroplasty was observed in the 50-70 age cohort. Notably, respondents favored reverse shoulder arthroplasty as the treatment modality of choice for individuals over 70 years of age. A treatment algorithm was developed to outline decision pathways concisely, considering these patient age groups and the option of reverse shoulder arthroplasty. This study provides clinically relevant insights into therapeutic decision-making processes in the management of proximal humeral fractures. The illustration of treatment preferences through a visualized algorithm serves as a crucial tool for evidence-based clinical decision-making, offering potential in enhancing the individualized care spectrum for patients with PHF.

1 May 2025 in Clinical Hemorheology and Microcirculation
Verified
Journal Article
Closed access
MAMichael Akers
Michael Akers
WBW Bäumler
W Bäumler
CSC Stroszczynski
C Stroszczynski
EJEm Jung
Em Jung
Objective: To evaluate the contribution of modern ultrasound imaging tools such as PDI or MVI in improving detection rate, anatomical visualization, and spectral analysis of the hepatic artery. Methods: The retrospective single-center study analyzed 40 patients undergoing regular ultrasound control in pre-existing vascular diseases of the liver and after liver transplantation or ablative interventions with furthermore limited examination conditions due to the patient's physique or irregular vascular status after medical treatment such as referred to above. To deal with these conditions, PDI as well as MVI were performed in addition to the standardized B-mode and CCDS. Image quality interpretation was obtained retrospectively by two advanced physicians, evaluating detection rate, anatomical visualization of the vessel itself and artefact-free spectral analysis of the hepatic artery. Results: All forty patients (28 men, 13 women, age 23–84 years, mean 60 ± 15 years, median 61 years) showed limited examination conditions and underwent analysis of the resistive index (RI) of the hepatic artery (0.56–0.77, mean 0.67 ± 0.06, median 0.67) by using CCDS, as well as PDI and MVI. The reading addressing the image quality resulted in an average value of 2.74 (median 3.00) ± 0.82 for CCDS in the standard device versus an average value of 3.70 ± 0.83 (median 4.00) in the competing device by combining PDI and MVI scores and when addressed separately 3.56 ± 1.02 (median 4.00) for PDI versus 3.58 ± 1.02 (4.00) for MVI. Overall image quality of the competing device combining PDI and MVI was significantly superior to the standard device only using CCDS for both readers in the detection and evaluation of the hepatic artery ( p  < 0.01) by providing a strong inter-reader reliability for each evaluation. Conclusion: Combination of PDI and MVI can improve detection and visualization of the hepatic artery and its anatomy in compromised examination settings, as well as artefact-free spectral analysis detecting hemodynamic changes.

25 August 2025 in RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
Verified
Conference Paper
Closed access
MAMichael Akers
Michael Akers
ORO Rompel
O Rompel
SSS Schulz-Heise
S Schulz-Heise
NNN Naumann-Bartsch
N Naumann-Bartsch
Anamnese: Männlicher Patient von 6 Jahren zum Zeitpunkt der Erstdiagnose eines Ewing-Sarkoms am linken Humerus im Februar 2023. Hierfür iEuroEwing-Protokoll von Februar bis November 2023. Im April 2024 ossäres Rezidiv am rechten proximalen Femur und Becken und Einleitung einer Rezidivtherapie nach rEECur-Protokoll mit Isofosfamid. Aufgrund unzureichender Response und neuer Metastasen sowie Neuro- und Nephrotoxizität Umstellung auf Irinotecan & Temozolomid (07/2024) und Rebiopsie zur Evaluation einer Target-Therapie (nach INFORM-Studienprotokoll). In diesem Rahmen Detektion eines Gangliosid-Oberflächenantigens (GD2) und hierdurch Möglichkeit einer Chimeric antigen receptor T-cell (CAR-T) Therapie (Phase-1-GD2IL18-Studie) im Sinne eines individuellen Heilversuches (Beginn 08.10.2024). Unter kontinuierlichem Monitoring mittels CAPD-Score (Cornell Assessment of Pediatric Delirium) frühzeitige Detektion therapieassoziierter Veränderungen eines Cytokin-Release-Syndroms (CRS, 15.10.2024, monoklonale Antikörpertherapie IL-6 Tocilizumab), nach Abklingen dessen eines Immuneffektorzell-assoziierten HLH-like Syndroms (IEC-HS, 17.10.2024, humaner IL-1 Rezeptorantagonist Anakinra) und im Verlauf unter neurologischer Verschlechterung (Kopfschmerz, Verwirrtheit und tonisch-klonischer Krampfanfall) sowie lymphozytärer Pleozytose (>90% CAR-T-Zellen) eines Immuneffektorzell-assoziierten Neurotoxizitätssyndroms (ICANS). Schutzintubation, Verlegung auf Intensivstation, Eskalation der bisherigen und Erweiterung der Gesamttherapie. Im Verlauf multiple infektiöse Komplikationen und zuletzt neurologische Verschlechterung (weite und lichtstarre Pupillen, Abnahme der Spontanmotorik, Verlust der Reagibilität auf Schmerzreize und Hirnstammreflexe), abnehmendes Flussprofil in der transkraniellen Dopplersonographie und neue EEG-Supprimierung. Indikation zur Limitierung der Therapiemaßnahmen. Exitus letalis am 15.11.2024 im Beisein der Eltern. Bildgebung: Unter CAR-T-Zell-Therapie neue ödematöse Veränderungen der Pons und der basalen Großhirnstiele (MRT, 25.10.2024). Im Verlauf regrediente ödematöse Veränderungen bei aber neu abgrenzbaren Signalalterationen der medialen Thalami (MRT, 27.10.2024). Unter klinischer Verschlechterung supratentoriell globale Signalalteration des Kortex in T2-FLAIR- und diffusionsgewichteter Sequenz mit kongruentem Signalabfall in der ADC ohne Schrankenstörung (MRT, 14.11.2024). In dieser Untersuchung zudem neue, bereits in nativer T1-gewichteter Sequenz hyperintense Signalalterationen der Nuclei caudati, einzelner subkortikaler Areale beiderseits frontal sowie von Putamen und Globus pallidus mit kontinuierlicher Fortleitung in Richtung Hirnstamm. Diagnose : Die MRT-Untersuchungen zeigten ein persistierendes vasogenes Ponsödem, im Verlauf mit zusätzlicher Ausbildung eines globalen zytotoxischen Kortexödems und Verdacht auf Nekrotisierung weiterer zentraler Hirnareale im Rahmen eines ICANS (Immuneffektorzell-assoziierten Neurotoxizitätssyndroms). Diskussion und Fazit: Nach dem CRS ist das ICANS die zweithäufigste Komplikation unter CAR-T-Zell-Therapie. Das CRS ist dabei oft – aber nicht zwingend – vorausgehend und die Kombination der beiden mit deutlich schlechterer Prognose behaftet. Innerhalb der ersten Tage bis wenigen Wochen nach Therapiebeginn ist mit dem Auftreten eines ICANS zu rechnen. Pathophysiologisch wird eine Störung der Blut-Hirn-Schranke im Rahmen der cytokinvermittelten Inflammationskaskaden vermutet. Diagnostisch führend sind EEG-Veränderungen, die MRT steht neben der Liquorpunktion als ergänzende diagnostische Maßnahme zur Verfügung. Bei der Bildgebung eines ICANS mittels MRT sind in der Literatur bislang keine spezifischen Veränderungen beschrieben. Im Initialstadium müssen diese wohl auch nicht zwingend vorliegen. Die MRT-Verdachtsdiagnose eines ICANS sollte nach unserer Meinung differentialdiagnostisch erwogen werden, wenn neben der klinischen Wahrscheinlichkeit in Abhängigkeit des Therapiezeitpunktes folgende Veränderungen vorliegen: vasogene Ödeme in Hirnstamm, Thalamus oder Cortex (T2/FLAIR), cytotoxische Ödeme (DWI/ADC), Mikrohämorrhagien (SWI) oder eine leptomeningeale Kontrastmittelaufnahme. Article published online: 25 August 2025 © 2025. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany